文献速递外周动脉疾病

基于办公室的实验室与门诊医院环境下外周动脉疾病外周血管介入治疗的实践模式比较

Practice patterns of peripheral vascular interventions for peripheral artery disease in the office-based laboratory setting versus outpatient hospital.
PubMed 文献 · J Vasc Surg · 2024-06-20

该研究利用2017年1月至2022年12月全美医疗保险按服务付费索赔数据,纳入848,526例外周血管介入(PVI)患者,比较基于办公室的实验室(OBL)与门诊医院两种服务场所的实践模式。结果显示OBL使用率从2017年48.3%升至2022年65.5%(P<.001),且与非白人患者可及性更高、诊断至治疗时间更短相关,但更常实施高成本介入(斑块旋切术等)和胫动脉介入。

要点

  • OBL使用率从2017年48.3%显著增至2022年65.5%(P<.001)。
  • OBL患者更可能为非白人、合并症较少、因跛行而非慢性肢体威胁性缺血接受治疗。
  • OBL更常实施斑块旋切术(aRRR 6.67)和胫动脉介入(跛行aRRR 3.18;CLTI aRRR 1.89)。

核心结论

  • OBL服务场所与非白人患者可及性更高和诊断至治疗时间更短相关,但较门诊医院更常实施高成本介入。
  • OBL改善外周动脉疾病诊疗可及性的获益必须与接受差异化诊疗的潜在局限性相平衡。

研究设计与样本

  • 回顾性队列研究,使用2017年1月至2022年12月100%医疗保险按服务付费索赔数据,纳入848,526例因跛行或慢性肢体威胁性缺血(CLTI)接受PVI的患者。
  • 采用多变量分层逻辑回归评估患者和手术特征与服务场所的关联,采用多项回归模型估计服务场所与介入类型及解剖水平的相对风险比(RRR),并按医生聚类调整。

主要发现

  • 848,526例PVI中485,942例(57.3%)在OBL实施,OBL使用率从2017年48.3%增至2022年65.5%(P<.001)。
  • OBL患者较门诊医院更可能为黑人(aOR 1.14;95%CI 1.11-1.18)或其他非白人种族(aOR 1.13;95%CI 1.08-1.18),合并症较少,因跛行而非CLTI治疗(aOR 1.30;95%CI 1.26-1.33)。
  • 多数执业(>50%手术)在OBL的医生更可能在城市环境执业(aOR 21.58;95%CI 9.31-50.02)、专攻放射学(aOR 18.15;95%CI 8.92-36.92)和高容量PVI实践(aOR 2.15;95%CI 2.10-2.29)。
  • 诊断至治疗中位时间OBL更短,尤其CLTI患者(29天 vs 39天;P<.001)。
  • OBL是患者单独接受斑块旋切术(aRRR 6.67;95%CI 6.59-6.76)或斑块旋切+支架(aRRR 10.84;95%CI 10.64-11.05)的最强预测因素,且按PVI指征分层亚组分析一致;OBL与跛行(aRRR 3.18;95%CI 3.11-3.25)和CLTI(aRRR 1.89;95%CI 1.86-1.92)胫动脉介入风险更高相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Controversy exists regarding the value and limitations of different sites of service for peripheral artery disease treatment. We aimed to examine practice patterns associated with peripheral vascular interventions (PVIs) performed in the office-based laboratory (OBL) vs outpatient hospital site of service using a nationally representative database. METHODS: Using 100% Medicare fee-for-service claims data, we identified all patients undergoing PVI for claudication or chronic limb-threatening ischemia (CLTI) between January 2017 and December 2022. We evaluated the associations of patient and procedure characteristics with site of service using multivariable hierarchical logistic regression. We used multinomial regression models to estimate the relative risk ratios (RRRs) of site of service and intervention type (angioplasty, stent, or atherectomy) and intervention anatomic level (iliac, femoropopliteal, or tibial) after adjusting for baseline patient characteristics and clustering by physician. RESULTS: Of 848,526 PVI, 485,942 (57.3%) were performed in an OBL. OBL use increased significantly over time from 48.3% in 2017 to 65.5% in 2022 (P < .001). Patients treated in OBLs were more likely to be Black (adjusted odds ratio [aOR], 1.14; 95% confidence interval [CI], 1.11-1.18) or other non-White race (aOR, 1.13; 95% CI, 1.08-1.18), have fewer comorbidities, and undergo treatment for claudication vs CLTI (aOR, 1.30; 95% CI, 1.26-1.33) compared with patients treated in outpatient hospital settings. Physicians with majority practice (>50% procedures) in an OBL were more likely to practice in urban settings (aOR, 21.58; 95% CI, 9.31-50.02), specialize in radiology (aOR, 18.15; 95% CI, 8.92- 36.92), and have high-volume PVI practices (aOR, 2.15; 95% CI, 2.10-2.29). The median time from diagnosis to treatment was shorter in OBLs, particularly for patients with CLTI (29 vs 39 days; P < .001). The OBL setting was the strongest predictor of patients receiving an atherectomy alone (adjusted RRR [aRRR] 6.67; 95% CI, 6.59-6.76) or atherectomy + stent (aRRR, 10.84; 95% CI, 10.64-11.05), and these findings were consistent in subgroup analyses stratified by PVI indication. The OBL setting was also associated with higher risk of tibial interventions for both claudication (aRRR, 3.18; 95% CI, 3.11-3.25) and CLTI (aRRR, 1.89; 95% CI, 1.86-1.92). The average reimbursement (including professional and facility fees) was slightly higher for OBLs compared with the hospital ($8742/case vs $8459/case; P < .001). However, in a simulated cohort resetting the OBL's intervention type distribution to that of the hospital, OBLs were associated with a hypothetical cost savings of $221,219,803 overall and $2602 per case. CONCLUSIONS: The OBL site of service was associated with greater access to care for non-White patients and a shorter time from diagnosis to treatment, but more frequently performed high-cost interventions compared with the outpatient hospital setting. The benefit to patients from improved access to peripheral artery disease care in OBL settings must be balanced with the potential limitations of receiving differential care.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tsou TC, Dun C, Bose S, et al. Practice patterns of peripheral vascular interventions for peripheral artery disease in the office-based laboratory setting versus outpatient hospital. J Vasc Surg. 2024. PMID: 38908807. doi:10.1016/j.jvs.2024.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。